Bradina Aaronalis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Bradina Aaronalis Pharmaceuticals
Bradina Aaronalis Pharmaceuticals Private Limited (BAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2021 (Three years and five months 10 days old ). Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pardeep Singh, Varinder Kumar, Sanjay Koul, and Two other members serve as directors at the Company.
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110PB2021PTC054203
- Company No.
054203
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Bradina Aaronalis Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pardeep Singh  | Director | 23-May-2022 | Current |
| Varinder Kumar | Director | 11-Sep-2021 | Current |
| Sanjay Koul | Director | 11-Sep-2021 | Current |
| Balbinder Kainth | Director | 02-Feb-2022 | Current |
| Amrinder Singh | Director | 23-May-2022 | Current |
Financial Performance of Bradina Aaronalis Pharmaceuticals.
Enhance accessibility to Bradina Aaronalis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bradina Aaronalis Pharmaceuticals?
Unlock access to Bradina Aaronalis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bradina Aaronalis Pharmaceuticals?
Unlock and access historical data on people associated with Bradina Aaronalis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bradina Aaronalis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bradina Aaronalis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
